May 18, 2018 / 4:49 PM / in 3 months

BRIEF-U.S. FDA Alerts Of Neural Tube Birth Defects Cases Reported In Babies Born To Women Treated With Dolutegravir

May 18 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA SAYS ALERTING PUBLIC TO SERIOUS CASES OF NEURAL TUBE BIRTH DEFECTS REPORTED IN BABIES BORN TO WOMEN TREATED WITH DOLUTEGRAVIR USED TO TREAT HIV

* SAYS PRELIM RESULTS FROM ONGOING STUDY FOUND WOMEN GETTING DOLUTEGRAVIR AT TIME OF BECOMING PREGNANT/EARLY IN FIRST TRIMESTER APPEAR AT HIGHER RISK FOR DEFECTS

* SAYS TO DATE, IN STUDY, THERE ARE NO REPORTED CASES OF BABIES BORN WITH NEURAL TUBE DEFECTS TO WOMEN STARTING DOLUTEGRAVIR LATER IN PREGNANCY Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below